Refine
Department, Institute
Document Type
- Article (26)
- Part of a Book (10)
- Conference Object (8)
- Preprint (3)
Year of publication
Keywords
- lignin (7)
- stem cells (7)
- biomaterial (4)
- drug release (4)
- osteogenesis (4)
- Biomass (3)
- Lignin (3)
- angiogenesis (3)
- biomass (3)
- bone (3)
Today, more than 70 million tons of lignin are produced by the pulp and paper industry every year. However, the utilization of lignin as a source for chemical synthesis is still limited due to the complex and heterogeneous lignin structure. The purpose of this study was a selective photodegradation of industrially available kraft lignin in order to obtain appropriate fragments and building block chemicals for further utilization, e.g. polymerization. Thus, kraft lignin obtained from soft wood black liquor by acidification was dissolved in sodium hydroxide and irradiated at a wavelength of 254 nm with and without the presence of titanium dioxide in various concentrations. Analyses of the irradiated products via SEC showed decreasing molar masses and decreasing polydispersity indices over time. At the end of the irradiation period the lignin was depolymerised to form fragments as small as the lignin monomers. TOC analyses showed minimal mineralisation due to the depolymerisation process.
Small Molecules Enhance Scaffold-Based Bone Grafts via Purinergic Receptor Signaling in Stem Cells
(2018)
The need for bone grafts is high, due to age-related diseases, such as tumor resections, but also accidents, risky sports, and military conflicts. The gold standard for bone grafting is the use of autografts from the iliac crest, but the limited amount of accessible material demands new sources of bone replacement. The use of mesenchymal stem cells or their descendant cells, namely osteoblast, the bone-building cells and endothelial cells for angiogenesis, combined with artificial scaffolds, is a new approach. Mesenchymal stem cells (MSCs) can be obtained from the patient themselves, or from donors, as they barely cause an immune response in the recipient. However, MSCs never fully differentiate in vitro which might lead to unwanted effects in vivo. Interestingly, purinergic receptors can positively influence the differentiation of both osteoblasts and endothelial cells, using specific artificial ligands. An overview is given on purinergic receptor signaling in the most-needed cell types involved in bone metabolism-namely osteoblasts, osteoclasts, and endothelial cells. Furthermore, different types of scaffolds and their production methods will be elucidated. Finally, recent patents on scaffold materials, as wells as purinergic receptor-influencing molecules which might impact bone grafting, are discussed.
Bioinspired stem cell-based hard tissue engineering includes numerous aspects: The synthesis and fabrication of appropriate scaffold materials, their analytical characterization, and guided osteogenesis using the sustained release of osteoinducing and/or osteoconducting drugs for mesenchymal stem cell differentiation, growth, and proliferation. Here, the effect of silicon- and silicate-containing materials on osteogenesis at the molecular level has been a particular focus within the last decade. This review summarizes recently published scientific results, including material developments and analysis, with a special focus on silicon hybrid bone composites. First, the sources, bioavailability, and functions of silicon on various tissues are discussed. The second focus is on the effects of calcium-silicate biomineralization and corresponding analytical methods in investigating osteogenesis and bone formation. Finally, recent developments in the manufacturing of Si-containing scaffolds are discussed, including in vitro and in vivo studies, as well as recently filed patents that focus on the influence of silicon on hard tissue formation.
Renewable resources gain increasing interest as source for environmentally benign biomaterials, such as drug encapsulation/release compounds, and scaffolds for tissue engineering in regenerative medicine. Being the second largest naturally abundant polymer, the interest in lignin valorization for biomedical utilization is rapidly growing. Depending on resource and isolation procedure, lignin shows specific antioxidant and antimicrobial activity. Today, efforts in research and industry are directed toward lignin utilization as renewable macromolecular building block for the preparation of polymeric drug encapsulation and scaffold materials. Within the last five years, remarkable progress has been made in isolation, functionalization and modification of lignin and lignin-derived compounds. However, literature so far mainly focuses lignin-derived fuels, lubricants and resins. The purpose of this review is to summarize the current state of the art and to highlight the most important results in the field of lignin-based materials for potential use in biomedicine (reported in 2014–2018). Special focus is drawn on lignin-derived nanomaterials for drug encapsulation and release as well as lignin hybrid materials used as scaffolds for guided bone regeneration in stem cell-based therapies.
Antioxidant activity is an essential feature required for oxygen-sensitive merchandise and goods, such as food and corresponding packaging as well as materials used in cosmetics and biomedicine. For example, vanillin, one of the most prominent antioxidants, is fabricated from lignin, the second most abundant natural polymer in the world. Antioxidant potential is primarily related to the termination of oxidation propagation reactions through hydrogen transfer. The application of technical lignin as a natural antioxidant has not yet been implemented in the industrial sector, mainly due to the complex heterogeneous structure and polydispersity of lignin. Thus, current research focuses on various isolation and purification strategies to improve the compatibility of lignin material with substrates and enhancing its stabilizing effect.
This review is divided into two interconnected parts, namely a biological and a chemical one. The focus of the first part is on the biological background for constructing tissue-engineered vascular grafts to promote vascular healing. Various cell types, such as embryonic, mesenchymal and induced pluripotent stem cells, progenitor cells and endothelial- and smooth muscle cells will be discussed with respect to their specific markers. The in vitro and in vivo models and their potential to treat vascular diseases are also introduced. The chemical part focuses on strategies using either artificial or natural polymers for scaffold fabrication, including decellularized cardiovascular tissue. An overview will be given on scaffold fabrication including conventional methods and nanotechnologies. Special attention is given to 3D network formation via different chemical and physical cross-linking methods. In particular, electron beam treatment is introduced as a method to combine 3D network formation and surface modification. The review includes recently published scientific data and patents which have been registered within the last decade.
Healing of large bone defects requires implants or scaffolds that provide structural guidance for cell growth, differentiation, and vascularization. In the present work, an agarose-hydroxyapatite composite scaffold was developed that acts not only as a 3D matrix, but also as a release system. Hydroxyapatite (HA) was incorporated into the agarose gels in situ in various ratios by a simple procedure consisting of precipitation, cooling, washing, and drying. The resulting gels were characterized regarding composition, porosity, mechanical properties, and biocompatibility. A pure phase of carbonated HA was identified in the scaffolds, which had pore sizes of up to several hundred micrometers. Mechanical testing revealed elastic moduli of up to 2.8 MPa for lyophilized composites. MTT testing on Lw35human mesenchymal stem cells (hMSCs) and osteosarcoma MG-63 cells proved the biocompatibility of the scaffolds. Furthermore, scaffolds were loaded with model drug compounds for guided hMSC differentiation. Different release kinetic models were evaluated for adenosine 5′-triphosphate (ATP) and suramin, and data showed a sustained release behavior over four days.
Nachhaltigkeitskonzepte sind kein selbstverständlicher Gegenstand der chemischen Hochschulausbildung. Der vorliegende Text fragt nach den Ursachen und zeigt anschließend Anschlussflächen für das Thema Nachhaltigkeit in der Chemieausbildung. Er stellt ein fachübergreifendes und zugleich fachbezogenes Konzept vor, welches Nachhaltigkeit zum Gegenstand für Chemiestudierende macht. Dieses ermöglicht den Studierenden einen subjektiv bedeutsamen Zugang zu den Fachinhalten. Es fördert Bewertungskompetenzen und Verantwortungsfähigkeit, schult die Sprachgewandtheit und erleichtert methodisch geführt die Reflexion auf Gegenstand und Selbstverständnis.
Mesenchymal Stem Cells
(2020)
This chapter focuses on mesenchymal stem cells (MSCs), a multipotent stem cell type that has been found in a variety of tissues and organs of the human body since their discovery in 1970. Their main function is to maintain and repair the respective tissue in vivo. Mesenchymal stem cells can be easily isolated from different tissues and can undergo extensive self-proliferation prior to differentiation into various mesodermal cell types such as osteoblasts, chondrocytes, adipocytes, tenocytes, myocytes, and fibroblasts. Because of this vast differentiation potential, mesenchymal stem cells are a promising tool for regenerative medicine approaches. They could play an important role in cellular therapy, tissue replacement and regeneration in the future. Mesenchymal stem cells will be compared for their application and differentiation potential to embryonic stem cells and induced pluripotent stem cells and the limitations and challenges using scaffolds for tissue repair will be presented. In addition, legal and ethical aspects of the use of mesenchymal stem cells will be discussed. Moreover, isolation protocols for mesenchymal stem cells from the most common sources namely bone marrow, adipose tissue and umbilical cord are included.
Atherosclerosis is a chronic disease of the arteries and accounts for about 50 percent of all deaths in industrialized countries. For its treatment, patients primarily need to undergo lifestyle changes, concerning their diet or sportive behavior, while additional pharmaceutical approaches help to reduce major risk factors such as hypertension and hyperlipidemia. However, these two areas of treatment are only briefly mentioned here. Instead, this article focuses on literature and patents from the last decade focusing on invasive surgical procedures necessary for treatment of diseased blood vessels in severe cases of atherosclerosis. Described herein are synthetic grafts and so-called autografts, which are harvested from the patient for bypass surgery. In addition, implantable stents are discussed, which deal with different atherosclerotic aspects, such as restenosis, re-endothelialization, neointimal hyperplasia and thrombosis. And finally, publications and inventions are presented from the relatively new field of artificial tissue engineering incorporating stem cells or biomaterials to construct new vessels as substitutes for diseased veins and arteries.
Three-dimensional scaffolds are known to directly influence proliferation and differentiation of mesenchymal stem cells into bone tissue due to their properties such as stiffness and topography. While conventional methods for chemical induction of differentiation processes are based on incorporation of growth factors and/or cytokines via blending or adhesion onto the scaffold surfaces, novel approaches use template-mediated biomineralization to mimic the stimuli stem cells receive in their natural niche. This chapter summarizes recent progresses in guided bone tissue engineering with particular focus on design and functionality of three dimensional scaffolds, chemical templates and promising approaches for the corresponding cellbased approaches for future therapies.
Recent approaches in scaffold engineering for bone defects feature hybrid hydrogels made of a polymeric network (retains water and provides light and porous structures) and inorganic ceramics (add mechanical strength and improve cell-adhesion). Innovative scaffold materials should also induce bone tissue formation and incorporation of stem cells (osteogenic differentiation) and/or growth factors (inducing/supporting differentiation). Recently, purinergic P2X and P2Y receptors have been found to significantly influence the osteogenic differentiation process of human mesenchymal stem cells (hMSC). (1) Aim of this work is to develop polysaccharide (PS) composites to be used as scaffolds containing complementary receptor ligands to enable guided stem cell differentiation towards bone formation.
Lignins in general have been extensively studied, though the relation between source, isolation method and application is rarely described. In the present work, lignin from different sources (wheat straw and beech wood) and isolation methods (steam explosion, Organosolv) has been characterized regarding their application as a chemical resource and polymeric material. A range of analytical methods were applied including elemental analysis, FT-IR, 31P NMR, SEC, Py-GC-MS and HPLC to gain information about establish the purity, structure, molecular weight, thermal behavior and to determine carbohydrate residues according to the NREL protocol. TGA and DSC were used to study the thermal behavior of the isolated lignins and showed relatively low glass transition temperatures around 120 °C and decomposition temperatures between 340 and 380 °C. NREL analysis presented a carbohydrate-free lignin fraction derived from beech wood via Organosolv process which has not been achieved to date. The finding of this work supports Organolsolv as an efficient method to isolate pure lignin fractions from beech wood with practical value in industry, in particular for application in polyurethanes and phenolic resins.
The main objective of this chapter is to explore the lignocellulose feedstock (LCF) biorefinery for industrial usage according to green chemistry principles. In particular, the isolation and valorization of lignin as one of the most interesting intermediates of LCF biorefineries is discussed, including lignin isolation, purification, and structure analysis. Structure elucidation involves various chromatographic, spectroscopic, microscopic, and thermochemical methods. Thus, basic structure–property relationships regarding the influence of biomass source and isolation process on lignin amount, constitution, and 3D structure are highlighted. Furthermore, storage effects on lignin structure and degradation effects are presented. Finally, potential applications are discussed, including novel lignin-based hydrogels, composite compounds (hybrids), and nanomaterials. Focus is drawn to antioxidant and antimicrobial activity of lignin for applications in packaging and biomedicine, that is, biomaterials for drug release and tissue engineering.
